Cargando…
Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles
B-Raf represents a critical physiological regulator of the Ras/RAF/MEK/ERK-pathway and a pharmacological target of growing clinical relevance, in particular in oncology. To understand how B-Raf itself is regulated, we combined mass spectrometry with genetic approaches to map its interactome in MCF-1...
Autores principales: | Eisenhardt, Anja E., Sprenger, Adrian, Röring, Michael, Herr, Ricarda, Weinberg, Florian, Köhler, Martin, Braun, Sandra, Orth, Joachim, Diedrich, Britta, Lanner, Ulrike, Tscherwinski, Natalja, Schuster, Simon, Dumaz, Nicolas, Schmidt, Enrico, Baumeister, Ralf, Schlosser, Andreas, Dengjel, Jörn, Brummer, Tilman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042004/ https://www.ncbi.nlm.nih.gov/pubmed/27034005 http://dx.doi.org/10.18632/oncotarget.8427 |
Ejemplares similares
-
Global gene expression profiling analysis reveals reduction of stemness after B-RAF inhibition in colorectal cancer cell lines
por: Boerries, Melanie, et al.
Publicado: (2015) -
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
por: Halbach, Sebastian, et al.
Publicado: (2013) -
Strong negative feedback from Erk to Raf confers robustness to MAPK signalling
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2011) -
BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
por: Herr, Ricarda, et al.
Publicado: (2015) -
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
por: Avery, Thomas Yul, et al.
Publicado: (2022)